Katrin Heider

Katrin Heider is a Global Development Scientist Director in Late Phase Oncology at AstraZeneca, where they focus on triple negative breast cancer. They have previously held positions at the University of Cambridge, working on early cancer detection using circulating tumor DNA, and contributed to various translational research projects. Katrin has also engaged in communications roles, such as coordinating the Building Bridges in Medical Science conference, and participated in the EnterpriseTECH program at Cambridge Judge Business School. They earned a PhD in Medical Sciences from the University of Cambridge and a Bachelor’s degree in Biology from Villanova University.